Artiva Biotherapeutics, Inc. (ARTV)
NASDAQ: ARTV · Real-Time Price · USD
7.18
+0.37 (5.43%)
Apr 13, 2026, 4:00 PM EDT - Market closed
Artiva Biotherapeutics Market Cap
Artiva Biotherapeutics has a market cap or net worth of $177.47 million as of April 14, 2026. Its market cap has increased by 100.12% in one year.
Market Cap
177.47M
Enterprise Value
80.40M
1-Year Change
100.12%
Ranking
Category
Stock Price
$7.18
Market Cap Chart
Since the IPO on July 19, 2024, Artiva Biotherapeutics's market cap has increased from $176.76M to $177.47M, an increase of 0.40%. That is a compound annual growth rate of 0.23%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 10, 2026 | 168.32M | 59.85% |
| Dec 31, 2025 | 105.30M | -56.99% |
| Dec 31, 2024 | 244.84M | 38.52% |
| Jul 19, 2024 | 176.76M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Acumen Pharmaceuticals | 178.37M |
| Tonix Pharmaceuticals Holding | 177.28M |
| Corbus Pharmaceuticals Holdings | 173.82M |
| Sagimet Biosciences | 172.70M |
| Precision BioSciences | 172.11M |
| Canton Strategic Holdings | 169.12M |
| Unicycive Therapeutics | 167.33M |
| Heron Therapeutics | 160.82M |